LSE:HIK (Hikma Pharmaceuticals PLC)
About HIK
Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The majority of Hikmas operations are in the United States, the Middle East and North Africa Region and Europe.
Hikma Pharmaceuticals PLC (LSE: HIK) Latest News
Investing Articles
I think these are the best shares to buy now for the next decade
Investing Articles
Down 30%, here’s a dirt-cheap FTSE 100 stock to buy on the dip
Investing Articles
I reckon these 2 FTSE 100 stocks are among the best shares to buy now
Investing Articles
These FTSE 100 stocks are big fallers. I think they’re too cheap
Investing Articles
Top British growth stocks to buy in June
Investing Articles
3 cheap FTSE 100 dividend shares I’d buy now and hold until 2032
Investing Articles
The UK economy slows down — 2 FTSE 100 growth stocks I’d buy
Investing Articles
3 FTSE 100 stocks that could significantly grow my wealth by 2030!
Investing Articles
2 cheap UK stocks to buy for the rotation into value
Investing Articles
1 FTSE 100 stock I would buy and hold